Comparison between Sheetal Universal IPO and Sunrest Lifescience IPO.
Sheetal Universal IPO is a SME Fixed Price IPO proposed to list at NSE SME while Sunrest Lifescience IPO is a SME Fixed Price proposed to list at NSE SME.
| Sheetal Universal IPO | Sunrest Lifescience IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Beeline Capital Advisors Pvt.Ltd. | Mark Corporate Advisors Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Skyline Financial Services Pvt.Ltd. |
| Market Maker | Spread X Securities Pvt.Ltd. | Svcm Securities Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Sheetal Universal IPO is up to ₹22.60 Cr whereas the issue size of the Sunrest Lifescience IPO is up to ₹10.30 Cr. The final issue price of Sheetal Universal IPO is ₹70.00 per share and of Sunrest Lifescience IPO is ₹84.00 per share.
| Sheetal Universal IPO | Sunrest Lifescience IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹70.00 per share | ₹84.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | 1600 shares |
| Fresh Issue Size | 32,28,000 shares | 12,25,600 shares |
| Fresh Issue Size (Amount) | up to ₹22.60 Cr | up to ₹10.30 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 32,28,000 shares | 12,25,600 shares |
| Issue Size Total (Amount) | up to ₹22.60 Cr | up to ₹10.30 Cr |
Sheetal Universal IPO opens on Dec 04, 2023, while Sunrest Lifescience IPO opens on Nov 07, 2023. The closing date of Sheetal Universal IPO and Sunrest Lifescience IPO is Dec 06, 2023, and Nov 09, 2023, respectively.
| Sheetal Universal IPO | Sunrest Lifescience IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Dec 04, 2023 | Nov 07, 2023 |
| Issue Close | Dec 06, 2023 | Nov 09, 2023 |
| Basis Of Allotment (Tentative) | Dec 07, 2023 | Nov 15, 2023 |
| Initiation of Refunds (Tentative) | Dec 08, 2023 | Nov 16, 2023 |
| Credit of Share (Tentative) | Dec 08, 2023 | Nov 17, 2023 |
| Listing date (Tentative) | Dec 11, 2023 | Nov 20, 2023 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Sheetal Universal IPO P/E ratio is 27.34, as compared to Sunrest Lifescience IPO P/E ratio of 12.33.
| Sheetal Universal IPO | Sunrest Lifescience IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Sheetal Universal Limited Financial Information (Restated Consolidated)Sheetal Universal Limited's revenue increased by 230.49% and profit after tax (PAT) rose by 602.4% between the financial year ending with March 31, 2023 and March 31, 2022.
| Sunrest Lifescience Limited Financial Information (Restated)Sunrest Lifescience Limited's revenue decreased by -8.32% and profit after tax (PAT) rose by 162.91% between the financial year ending with March 31, 2023 and March 31, 2022.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 95 | 100 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 66.81 | 69.91 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 27.34 | 12.33 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹80.19 Cr. | ₹36.05 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 36.17% | 53% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 21.59% | 98% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 2.09 | 0.64 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹2.56 | ₹6.81 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 30.63% | 65.59% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Sheetal Universal IPO Retail Individual Investors (RII) are offered 16,14,000 shares while in Sunrest Lifescience IPO retail investors are offered 16,14,000 shares. Qualified Institutional Buyers (QIB) are offered in Sheetal Universal IPO and in Sunrest Lifescience IPO.
| Sheetal Universal IPO | Sunrest Lifescience IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | 1,72,000 shares | 65,600 shares |
| QIB | ||
| NII | 16,14,000 shares | 6,12,800 shares |
| RII | 16,14,000 shares | 6,12,800 shares |
| Employee | ||
| Others | ||
| Total | 32,28,000 shares | 12,25,600 shares |
Sheetal Universal IPO subscribed 179.20x in total, whereas Sunrest Lifescience IPO subscribed 48.54x.
| Sheetal Universal IPO | Sunrest Lifescience IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 212.55x | 29.17x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 129.73x | 65.74x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 179.20x | 48.54x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
